10-QPeriod: Q2 FY2004

THERMO FISHER SCIENTIFIC INC. Quarterly Report for Q2 Ended Apr 3, 2004

Filed May 10, 2004For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) reported solid first-quarter 2004 results, demonstrating a significant increase in revenue and operating income compared to the prior year. Revenue growth was driven by a combination of organic demand recovery across key segments, favorable currency translations, and strategic acquisitions, including Jouan SA. The company's Life and Laboratory Sciences segment showed particular strength, benefiting from increased demand for instruments and recovery in pharmaceutical markets. While restructuring costs impacted margins, overall profitability improved, reflecting successful cost management and integration efforts from prior acquisitions. The company's balance sheet remains robust, with a healthy increase in cash and cash equivalents. Management highlighted strong operating cash flow generation, which supports ongoing business needs and strategic investments. The company reiterated its confidence in its liquidity position, citing sufficient cash, investments, and available credit facilities to meet future capital requirements for at least the next 24 months. Despite ongoing market uncertainties and potential risks outlined in their forward-looking statements, TMO presented a positive outlook, emphasizing continued demand recovery and effective integration of acquired businesses.

Key Highlights

  • 1Revenue increased by 16% year-over-year to $582.0 million, driven by a 5% organic increase in sales, favorable currency translations, and strategic acquisitions.
  • 2Operating income improved significantly to $57.9 million from $39.3 million in the prior year, with the operating income margin expanding to 9.9% from 7.9%.
  • 3The Life and Laboratory Sciences segment was a key growth driver, with revenues up 21.9% due to strong demand for instruments and recovery in pharmaceutical markets.
  • 4Net income from continuing operations rose to $43.1 million, or $0.26 per diluted share, compared to $31.4 million, or $0.19 per diluted share, in the prior year.
  • 5Cash flow from operating activities showed a substantial improvement, increasing to $46.5 million from $12.4 million in the first quarter of 2003.
  • 6The company's cash and cash equivalents increased to $353.0 million as of April 3, 2004, up from $303.9 million at the end of 2003, reflecting strong cash generation.
  • 7A subsequent event notes the acquisition of US Counseling Services, Inc. (USCS) for approximately $78 million in cash, which closed on April 20, 2004, further expanding the company's offerings.

Frequently Asked Questions

Revenue growth was primarily driven by a combination of factors: a 5% increase in organic sales due to recovering worldwide economic conditions and increased demand, favorable currency translations which boosted reported revenues by $34.2 million, and the impact of strategic acquisitions, notably Jouan SA, Laboratory Management Systems, Inc. (LMSi), and the Siemens plc product line.

Profitability saw a significant improvement. Operating income increased to $57.9 million from $39.3 million in the prior year, leading to an expansion of the operating income margin from 7.9% to 9.9%. This improvement was attributed to higher sales across segments and a lower cost base following recent restructuring actions.

The company maintains a strong liquidity position. Cash and cash equivalents stood at $353.0 million as of April 3, 2004, an increase from $303.9 million at year-end 2003. Operating cash flow also improved significantly. Management believes existing resources, future operating cash flow, and available credit facilities are sufficient to meet capital requirements for at least the next 24 months.

During the first quarter of 2004, the company finalized purchase price allocation for the acquisition of Jouan SA, which closed on December 31, 2003. Additionally, on April 20, 2004, the company acquired US Counseling Services, Inc. (USCS) for approximately $78 million in cash. There were also mentions of prior divestitures impacting revenues.